Kestra Medical Technologies (KMTS) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
Annual meeting scheduled for September 3, 2025, to be held virtually for shareholder participation.
Shareholders are encouraged to review proxy materials and vote by September 2, 2025.
Voting matters and shareholder proposals
Election of Conor Hanley and Elizabeth Kwo as Class I directors to serve until the 2028 annual meeting.
Ratification of PricewaterhouseCoopers as independent registered accounting firm for fiscal year ending April 30, 2026.
Approval of the 2025 Employee Stock Purchase Plan is up for vote.
Board recommends voting in favor of all proposals.
Board of directors and corporate governance
Two director nominees, Conor Hanley and Elizabeth Kwo, are proposed for election as Class I directors.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Kestra Medical Technologies
- Clinically proven WCD platform drives rapid growth in a $10B U.S. cardiac care market.KMTS
Company presentation18 Mar 2026 - Q3 FY26 revenue up 63% to $24.6M, gross margin 52.6%, and FY26 guidance raised to $93M.KMTS
Q3 202617 Mar 2026 - Strong clinical data and innovation drive rapid growth and margin expansion in the WCD market.KMTS
44th Annual J.P. Morgan Healthcare Conference13 Jan 2026 - Innovative WCD platform drives rapid growth, margin expansion, and broad payor coverage.KMTS
Company presentation13 Jan 2026 - Q3 revenue up 82% to $15.1M, gross margin at 43.4%, and IPO proceeds boost growth outlook.KMTS
Q3 202527 Dec 2025 - Q2 revenue up 53% to $22.6M, gross margin at 50.6%, FY26 guidance raised to $91M.KMTS
Q2 202612 Dec 2025 - Shareholders will vote on director elections, auditor ratification, and a new employee stock plan.KMTS
Proxy Filing2 Dec 2025 - Rapidly scaling, clinically proven WCD platform drives growth in a $10B+ underpenetrated market.KMTS
Company Presentation1 Dec 2025 - Offering 5.5M shares at $26.98 to fund growth in a $24B global wearable defibrillator market.KMTS
Registration Filing1 Dec 2025